The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Fear extinction and BDNF: translating animal models of PTSD to the clinic
Open accessAbstract
Brain‐derived neurotrophic factor (BDNF) is the most studied neurotrophin involved in synaptic plasticity processes that are required for long‐term learning and memory. Specifically, BDNF gene expression and activation of its high‐affinity tropomyosin‐related kinase B (TrkB) receptor are necessary in the amygdala, hippocampus and prefrontal cortex for the formation of emotional memories, including fear memories. Among the psychiatric disorders with altered fear processing, there is post‐traumatic stress disorder (PTSD) which is characterized by an inability to extinguish fear memories. Since BDNF appears to enhance extinction of fear, targeting impaired extinction in anxiety disorders such as PTSD via BDNF signalling may be an important and novel way to enhance treatment efficacy. The aim of this review is to provide a translational point of view that stems from findings in the BDNF regulation of synaptic plasticity and fear extinction. In addition, there are different systems that seem to alter fear extinction through BDNF modulation like the endocannabinoid system and the hypothalamic–pituitary adrenal axis. Recent work also finds that the pituitary adenylate cyclase‐activating polypeptide and PAC1 receptor, which are upstream of BDNF activation, may be implicated in PTSD. Especially interesting are data that exogenous fear extinction enhancers such as antidepressants, histone deacetylases inhibitors and d‐cycloserine, a partial N‐methyl d‐aspartate agonist, may act through or in concert with the BDNF–TrkB system. Finally, we review studies where recombinant BDNF and a putative TrkB agonist, 7,8‐dihydroxyflavone, may enhance extinction of fear. These approaches may lead to novel agents that improve extinction in animal models and eventually humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“The Val66Met SNP causes decreased hippocampal volume, deficits in declarative memory and impaired fear extinction (Egan et al., 2003; Bueller et al., 2006; Soliman et al., 2010).”
BackgroundNeurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298
Neurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Fear Extinction as a Model for Translational Neuroscience: Ten Years of Progress
Milad, M. R., & Quirk, G. J. (2012) · Annual Review of Psychology · doi:10.1146/annurev.psych.121208.131631 · Cited by 1,466 · cited 1×
“The most important substructures related to fear processing in the PFC are the dorsal anterior cingulate cortex (prelimbic cortex, PL, in rodents) and the ventromedial prefrontal cortex (infralimbic cortex, IL, in rodents) (Milad & Quirk 2012).”
BackgroundSmith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8856 · Cited by 1,426
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
Long-Lasting Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult Hippocampus
Kang, H., & Schuman, E. M. (1995) · Science · doi:10.1126/science.7886457 · Cited by 1,354
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
Myers, K. M., & Davis, M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001939 · Cited by 1,277 · cited 19×
“PL and IL, both substructures of the medial prefrontal cortex (mPFC), appear to have opposing influences on fear processes.”
BackgroundInfluentialPatterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233 · cited 2×
“However, BDNF heterozygous knockout mice present a viable, but altered, phenotype including impaired hippocampus-LTP and deficits in the acquisition of contextual fear conditioning, which are both rescued by rBDNF infusion (Korte et al. 1995; Liu et al. 2004; Patterson et al. 1996).”
BackgroundSierra-Mercado, D., Padilla-Coreano, N., & Quirk, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.184 · Cited by 1,190 · cited 4×
“Muscimol inactivation suggests that PL is necessary for fear acquisition but not extinction, whereas IL is required for fear extinction but not fear acquisition (Sierra-Mercado et al. 2011).”
BackgroundInfluentialMice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067 · cited 2×
“BDNF or TrkB homozygous knockout mice rarely survive beyond the third week of life and if they survive have serious health problems and extreme phenotype abnormalities (Klein et al., 1993; Ernfors et al. 1994).”
BackgroundRessler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Self-citationTrkB signalling pathways in LTP and learning
Minichiello, L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2738 · Cited by 1,055
Mouse and rat BDNF gene structure and expression revisited
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., & Timmusk, T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21139 · Cited by 943
Chen, Z.-Y., Patel, P. D., Sant, G., Meng, C.-X., Teng, K. K., Hempstead, B. L., & Lee, F. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0348-04.2004 · Cited by 874
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Self-citationEpigenetic Regulation of bdnf Gene Transcription in the Consolidation of Fear Memory
Lubin, F. D., Roth, T. L., & Sweatt, J. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1786-08.2008 · Cited by 793
Ying, S.-W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V. P., & Bramham, C. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01532.2002 · Cited by 784 · cited 2×
“Concordantly, rBDNF administered in the hippocampus in vivo or in slices induces long-lasting enhancement of synaptic plasticity (Kang et al. 1995; Messaoudi et al. 2002; Ying et al. 2002).”
BackgroundKlein, R., Smeyne, R. J., Wurst, W., Long, L. K., Auerbach, B. A., Joyner, A. L., & Barbacid, M. (1993) · Cell · doi:10.1016/0092-8674(93)90683-h · Cited by 699
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686
Heldt, S. A., Stanek, L., Chhatwal, J. P., & Ressler, K. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001957 · Cited by 684
Self-citationMahan, A. L., & Ressler, K. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.007 · Cited by 613
Self-citationA Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human
Soliman, F., Glatt, C. E., Bath, K. G., Levita, L., Jones, R. M., Pattwell, S. S., Jing, D., Tottenham, N., Amso, D., Somerville, L. H., et al. (2010) · Science · doi:10.1126/science.1181886 · Cited by 585 · cited 3×
“…hippocampal volume and LTP which may result in the declarative memory and fear extinction deficits found in these BDNF Met66 knock-in mice (Chen et al. 2004, 2005, 2006; Cao et al. 2007; Frielingsdorf et al. 2010; Ninan et al. 2010; Soliman et al. 2010; Spencer et al. 2010; Yu et al. 2009).”
BackgroundAugmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 1×
“…receptor partial agonist and it has been shown to be an effective drug to facilitate consolidation of fear extinction in different anxiety disorders (Guastella et al. 2008; Hofmann et al. 2006; Kushner et al. 2007; Otto et al. 2010; Ressler et al. 2004; Storch et al. 2010; Wilhelm et al. 2008).”
BackgroundBredy, T. W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y. E., & Barad, M. (2007) · Learning & Memory · doi:10.1101/lm.500907 · Cited by 548
Induction of Fear Extinction with Hippocampal-Infralimbic BDNF
Peters, J., Dieppa-Perea, L. M., Melendez, L. M., & Quirk, G. J. (2010) · Science · doi:10.1126/science.1186909 · Cited by 462
BDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects
Bueller, J. A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M., & Zubieta, J.-K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.022 · Cited by 460
Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents
Massa, S. M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J. N., Nehama, D., Rajadas, J., & Longo, F. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41356 · Cited by 406
Xu, B., Gottschalk, W., Chow, A., Wilson, R. I., Schnell, E., Zang, K., Wang, D., Nicoll, R. A., Lu, B., & Reichardt, L. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06888.2000 · Cited by 406
Chen, Z.-Y., Ieraci, A., Teng, H., Dall, H., Meng, C.-X., Herrera, D. G., Nykjaer, A., Hempstead, B. L., & Lee, F. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1017-05.2005 · Cited by 401
D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder
Kushner, M. G., Kim, S. W., Donahue, C., Thuras, P., Adson, D., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384
Fear erasure in mice requires synergy between antidepressant drugs and extinction training
Karpova, N. N., Pickenhagen, A., Lindholm, J., Tiraboschi, E., Kulesskaya, N., Ágústsdóttir, A., Antila, H., Popova, D., Akamine, Y., Sullivan, R., et al. (2011) · Science · doi:10.1126/science.1214592 · Cited by 382
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378 · cited 2×
“It has been recently reported that epigenetic regulation of BDNF gene could be crucial in depression (Fuchikami et al. 2011).”
BackgroundRattiner, L. M., Davis, M., French, C. T., & Ressler, K. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5654-03.2004 · Cited by 361
Self-citationAugmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358
Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358
Guastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.011 · Cited by 326
Messaoudi, E., Ying, S.-W., Kanhema, T., Croll, S. D., & Bramham, C. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07453.2002 · Cited by 302
Devi, L., & Ohno, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.191 · Cited by 282
Marmigère, F., Givalois, L., Rage, F., Arancibia, S., & Tapia‐Arancibia, L. (2003) · Hippocampus · doi:10.1002/hipo.10109 · Cited by 253
Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251
Bredy, T. W., & Barad, M. (2008) · Learning & Memory · doi:10.1101/lm.801108 · Cited by 246
Amygdala BDNF signaling is required for consolidation but not encoding of extinction
Chhatwal, J. P., Stanek-Rattiner, L., Davis, M., & Ressler, K. J. (2006) · Nature Neuroscience · doi:10.1038/nn1718 · Cited by 241
Self-citationSystemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction.
Lattal, K. M., Barrett, R. M., & Wood, M. A. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.5.1125 · Cited by 234
Hammack, S. E., Cheung, J., Rhodes, K. M., Schutz, K. C., Falls, W. A., Braas, K. M., & May, V. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.013 · Cited by 231
Effect of 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, on Emotional Learning
Andero, R., Heldt, S. A., Ye, K., Liu, X., Armario, A., & Ressler, K. J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030326 · Cited by 226
Self-citationA History of Corticosterone Exposure Regulates Fear Extinction and Cortical NR2B, GluR2/3, and BDNF
Gourley, S. L., Kedves, A. T., Olausson, P., & Taylor, J. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.123 · Cited by 218 · cited 1×
“There is only one study about the HPA axis–BDNF regulation combined with fear extinction (Gourley et al. 2009).”
BackgroundCombined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)
Hetrick, S. E., Purcell, R., Garner, B., & Parslow, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007316.pub2 · Cited by 212
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear
Choi, D. C., Maguschak, K. A., Ye, K., Jang, S.-W., Myers, K. M., & Ressler, K. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909359107 · Cited by 212 · cited 7×
“The most common pharmacological treatment for PTSD is antidepressants alone and there are few studies combining antidepressants with exposure psychotherapy (Choi et al. 2010b; Hetrick et al. 2010).”
BackgroundInfluentialSelf-citationLiu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., Phun, L. H., France, S., Xiao, G., Jia, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101206p · Cited by 208
Marini, A. M., Rabin, S. J., Lipsky, R. H., & Mocchetti, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29394 · Cited by 202
Mehta, D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.50 · Cited by 200 · cited 2×
“Examples of genetic variation related to PTSD risk are FKBP5, Serotonin transporter gene variants SLC6A4 and 5-HTTLPR, and RGS2 (Binder et al., 2008; Amstadter et al., 2009; Koenen et al., 2009; Mehta et al., 2011; Mercer et al., 2012; Wang et al., 2011).”
BackgroundZhang, H., Ozbay, F., Lappalainen, J., Kranzler, H. R., van Dyck, C. H., Charney, D. S., Price, L. H., Southwick, S., Yang, B., Rasmussen, A., et al. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30332 · Cited by 194
Storch, E. A., Murphy, T. K., Goodman, W. K., Geffken, G. R., Lewin, A. B., Henin, A., Micco, J. A., Sprich, S., Wilhelm, S., Bengtson, M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.015 · Cited by 193
PTSD and gene variants: new pathways and new thinking
Skelton, K., Ressler, K. J., Norrholm, S. D., Jovanovic, T., & Bradley-Davino, B. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.013 · Cited by 191
Self-citationBrain-Derived Neurotrophic Factor Plays a Critical Role in Contextual Fear Conditioning
Liu, I. Y. C., Lyons, W. E., Mamounas, L. A., & Thompson, R. F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1948-04.2004 · Cited by 190
Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers
Blugeot, A., Rivat, C., Bouvier, E., Molet, J., Mouchard, A., Zeau, B., Bernard, C., Benoliel, J.-J., & Becker, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1309-11.2011 · Cited by 189
BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice
Aso, E., Ozaita, A., Valdizán, E. M., Ledent, C., Pazos, Á., Maldonado, R., & Valverde, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05149.x · Cited by 189
Khaspekov, L. G., Brenz Verca, M. S., Frumkina, L. E., Hermann, H., Marsicano, G., & Lutz, B. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03285.x · Cited by 184
Cornelis, M. C., Nugent, N. R., Amstadter, A. B., & Koenen, K. C. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0126-6 · Cited by 180
Ninan, I., Bath, K. G., Dagar, K., Perez-Castro, R., Plummer, M. R., Lee, F. S., & Chao, M. V. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1405-10.2010 · Cited by 180
Yaka, R., He, D.-Y., Phamluong, K., & Ron, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209141200 · Cited by 174
Dell’Osso, L., Carmassi, C., Debbio, A. D., Dell’Osso, M. C., Bianchi, C., Pozzo, E. D., Origlia, N., Domenici, L., Massimetti, G., Marazziti, D., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.04.018 · Cited by 173
Glutamate Receptors in Extinction and Extinction-Based Therapies for Psychiatric Illness
Myers, K. M., Carlezon, W. A., & Davis, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.88 · Cited by 173
Koponen, E., Võikar, V., Riekki, R., Saarelainen, T., Rauramaa, T., Rauvala, H., Taira, T., & Castrén, E. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.006 · Cited by 170 · cited 2×
“mice overexpressing TrkB receptors have enhanced contextual fear conditioning (Koponen et al. 2004).”
BackgroundBDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.318 · Cited by 169 · cited 2×
“The second one shows how the BDNF Met66 knock-in mice present impaired fluoxetine-induced enhancement of hippocampal synaptic plasticity (Bath et al., 2012).”
BackgroundVariant BDNF Val66Met Polymorphism Affects Extinction of Conditioned Aversive Memory
Yu, H., Wang, Y., Pattwell, S. S., Jing, D., Liu, T., Zhang, Y., Bath, K. G., Lee, F. S., & Chen, Z.-Y. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5539-08.2009 · Cited by 162
Koenen, K. C., Aiello, A. E., Bakshis, E., Amstadter, A. B., Ruggiero, K. J., Acierno, R. E., Kilpatrick, D. G., Gelernter, J. E., & Galea, S. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn397 · Cited by 159
Frielingsdorf, H., Bath, K. G., Soliman, F., Difede, J., Casey, B. J., & Lee, F. S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05722.x · Cited by 156
Rattiner, L. M., Davis, M. E., & Ressler, K. J. (2004) · Learning & Memory · doi:10.1101/lm.83304 · Cited by 151
Self-citationTabuchi, A., Nakaoka, R., Amano, K., Yukimine, M., Andoh, T., Kuraishi, Y., & Tsuda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909538199 · Cited by 150
Maddox, S. A., & Schafe, G. E. (2011) · Learning & Memory · doi:10.1101/lm.2243411 · Cited by 146
Takei, S., Morinobu, S., Yamamoto, S., Fuchikami, M., Matsumoto, T., & Yamawaki, S. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.08.009 · Cited by 143
Neuroprotection in experimental stroke with targeted neurotrophins
Wu, D. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.120 · Cited by 140
D’Souza, D. C., Pittman, B. P., Perry, E. B., & Simen, A. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1333-2 · Cited by 133
Genetic Modulation of BDNF Signaling Affects the Outcome of Axonal Competition In Vivo
Cao, L., Albers, A. D., Mukai, J., Blazeski, R., Lodovichi, C., Mason, C. A., & Gogos, J. A. (2007) · Current Biology · doi:10.1016/j.cub.2007.04.040 · Cited by 127
Amstadter, A. B., Koenen, K. C., Ruggiero, K. J., Acierno, R. E., Galea, S., Kilpatrick, D. G., & Gelernter, J. E. (2008) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2008.12.005 · Cited by 126
Rakofsky, J. J., Ressler, K. J., & Dunlop, B. W. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.121 · Cited by 120
Self-citationGenetics of anxiety and trauma-related disorders
Norrholm, S. D., & Ressler, K. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.036 · Cited by 115
Self-citationSerum brain-derived neurotrophic factor in patients with trauma psychopathology
Hauck, S., Kapczinski, F. P., Roesler, R., Júnior, É. D. M. S., Magalhães, P. V. D. S., Kruel, L. R. P., Schestatsky, S., & Ceitlin, L. H. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.010 · Cited by 107
Andero, R., Daviu, N., Escorihuela, R. M., Nadal, R. A., & Armario, A. (2010) · Hippocampus · doi:10.1002/hipo.20906 · Cited by 104
Self-citationDeoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Self-citationLin, Y., Ter Horst, G. J., Wichmann, R., Bakker, P., Liu, A., Li, X., & Westenbroek, C. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn225 · Cited by 100 · cited 2×
“…is complex because these stress-induced BDNF/TrkB alterations are regionally dependent and influenced by several factors, such as stress paradigm, stress duration and sex (Greenwood et al. 2007; Lin et al. 2009; Marmigere et al. 2003; Molteni et al. 2001; Molteni et al. 2010; Smith et al. 1995).”
BackgroundYang, Y.-L., & Lu, K. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.003 · Cited by 95
Molteni, R., Lipska, B. K., Weinberger, D. R., Racagni, G., & Riva, M. A. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000865 · Cited by 89
Valente, N. L. M., Vallada, H., Cordeiro, Q., Miguita, K., Bressan, R. A., Andreoli, S. B., Mari, J. D. J., & Mello, M. F. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9513-7 · Cited by 85
A High Risk Twin Study of Combat-Related PTSD Comorbidity
Koenen, K. C., Lyons, M. J., Goldberg, J. H., Simpson, J., Williams, W. M., Toomey, R., Eisen, S. A., True, W. R., Cloître, M., Wolfe, J., et al. (2003) · Twin Research · doi:10.1375/136905203765693870 · Cited by 85
BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function
Spencer-Segal, J. L., Waters, E. M., Milner, T. A., Lee, F. S., & McEwen, B. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915105107 · Cited by 83
Wang, Z., Baker, D. G., Harrer, J., Hamner, M. B., Price, M., & Amstadter, A. B. (2011) · Depression and Anxiety · doi:10.1002/da.20872 · Cited by 83
Modulation of Fear and Anxiety by the Endogenous Cannabinoid System
Chhatwal, J. P., & Ressler, K. J. (2007) · CNS Spectrums · doi:10.1017/s1092852900020939 · Cited by 80
Self-citationBDNF regulates neuronal sensitivity to endocannabinoids
Maison, P., Walker, D. J., Walsh, F. S., Williams, G. H., & Doherty, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.011 · Cited by 75
BDNF Evokes Release of Endogenous Cannabinoids at Layer 2/3 Inhibitory Synapses in the Neocortex
Lemtiri‐Chlieh, F., & Levine, E. S. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00472.2010 · Cited by 75
Mercer, K. B., Orcutt, H. K., Quinn, J. F., Fitzgerald, C. A., Conneely, K. N., Barfield, R. T., Gillespie, C. F., & Ressler, K. J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.109 · Cited by 71
Self-citationMolteni, R., Chourbaji, S., Brandwein, C., Racagni, G., Gass, P., & Riva, M. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108099815 · Cited by 65
Li, C., Dabrowska, J., Hazra, R., & Rainnie, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026065 · Cited by 65
Berger, W., Mehra, A., Lenoci, M., Metzler, T. J., Otte, C., Tarasovsky, G., Mellon, S. H., Wolkowitz, O. M., Marmar, C. R., & Neylan, T. C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.008 · Cited by 62
Greenwood, B. N., Strong, P. V., Foley, T. E., Thompson, R. S., & Fleshner, M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.007 · Cited by 61
Lee, H., Kang, R.-H., Lim, S., Paik, J., Choi, M.-J., & Lee, M.-S. (2006) · Stress and Health · doi:10.1002/smi.1085 · Cited by 51
BDNF-TrkB signalling in fear learning: from genetics to neural networks
Musumeci, G., & Minichiello, L. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.031 · Cited by 51
Pharmacological Enhancement of Behavioral Therapy: Focus on Posttraumatic Stress Disorder
Choi, D. C., ROTHBAUM, B. O., Gerardi, M. A., & Ressler, K. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_10 · Cited by 50
Self-citationThe exclusive induction of extinction is gated by BDNF
Kirtley, A., & Thomas, K. L. (2010) · Learning & Memory · doi:10.1101/lm.1877010 · Cited by 37
Posttraumatic stress disorder and late-onset smoking in the Vietnam era twin registry.
Koenen, K. C., Hitsman, B. L., Lyons, M. J., Stroud, L. R., NIAURA, R. S., McCaffery, J. M., Goldberg, J. H., Eisen, S. A., True, W., & Tsuang, M. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.1.186 · Cited by 35
Zink, M., Otto, C., Zörner, B., Zacher, C., Schütz, G., Henn, F. A., & Gass, P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.030 · Cited by 33
Cited by
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
Implications of memory modulation for post-traumatic stress and fear disorders
Parsons, R. G., & Ressler, K. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3296 · Cited by 476
Self-citationThe Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders
Smoller, J. W. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.266 · Cited by 480
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“…plasticity in addition to reduced extinction acquisition (Ninan et al., 2010) that is rescued by systemic administration of D-cycloserine (Yu et al., 2009), underscoring an additional strong interaction between BDNF and the glutamatergic system [see (Andero & Ressler, 2012) for more details].”
BackgroundSelf-citationHippocampal–Prefrontal BDNF and Memory for Fear Extinction
Rosas-Vidal, L. E., Do-Monte, F. H., Sotres-Bayon, F., & Quirk, G. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.64 · Cited by 184
Metadata
- Authors
- Andero, R., & Ressler, K. J.
- Venue
- Genes, Brain and Behavior
- Publisher
- Wiley
- Published
- 2012-05-11
- Volume
- 11
- Issue
- 5
- Pages
- 503-512
- ISSN
- 1601-183X (ISSN-L)
- 1601-1848
- OpenAlex
- W2073927880
- Cited by
- 276
- References
- 105
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.